ÂÜÀòÂÒÂ×

Marc Posel has over 25 years of experience in the finance and accounting industry. Marc started their career in 1992 as a Senior Auditor for KPMG US, and then moved to PwC in 1994 as an Audit Manager. In 1999, they became the Corporate Controller for JNI Corporation, and then moved to Cogent Systems in 2004 in the same role. In 2008, they became the Corporate Controller for Advanced BioHealing, and then moved to Shire Pharmaceuticals in 2011 as the Financial Operations Director. In 2014, they were the Corporate Controller for Agena Bioscience and the Director of Finance for Ansun Biopharma, Inc. Currently, Marc Posel is the VP, Corporate Controller for ReCode Therapeutics.

Marc Posel obtained a Bachelor of Business Administration (B.B.A.) in Accounting from The University of Texas at Austin between 1988 and 1992.